Intellia Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 08/14/2026 | 16.88 M | $285.54 M | 16.31% | 12.64% |
| BLACKROCK, INC. | 08/07/2026 | 15.41 M | $260.72 M | 26.76% | 11.54% |
| STATE STREET CORP | 08/07/2026 | 9.23 M | $156.26 M | 33.40% | 6.92% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 7.33 M | $124.06 M | 17.82% | 5.49% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 6.44 M | $109.02 M | 12.48% | 4.83% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 6.03 M | $102.00 M | 18.58% | 4.52% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 5.24 M | $88.58 M | 11.25% | 3.92% |
| FMR LLC | 08/13/2026 | 4.77 M | $80.76 M | 130.89% | 3.58% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 4.53 M | $76.60 M | 100.00% | 3.39% |
| REGENERON PHARMACEUTICALS, INC. | 08/07/2026 | 3.70 M | $62.65 M | 0.00% | 2.77% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 3.63 M | $61.45 M | 27.34% | 2.72% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 3.28 M | $55.51 M | 134.80% | 2.46% |
| SUMITOMO MITSUI TRUST GROUP, INC. | 07/30/2026 | 2.90 M | $49.03 M | 46.85% | 2.17% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 08/13/2026 | 2.90 M | $49.03 M | 46.85% | 2.17% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 2.60 M | $44.04 M | 12.29% | 1.95% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 2.26 M | $38.31 M | 39.07% | 1.70% |
| UBS GROUP AG | 08/13/2026 | 2.15 M | $36.43 M | -19.95% | 1.61% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 2.07 M | $34.96 M | 28.22% | 1.55% |
| CONTRARIUS GROUP HOLDINGS LTD | 08/11/2026 | 1.96 M | $33.08 M | 2.27% | 1.46% |
| JUPITER ASSET MANAGEMENT LTD | 08/10/2026 | 1.85 M | $31.29 M | 3.84% | 1.39% |
| MORGAN STANLEY | 08/13/2026 | 1.73 M | $29.30 M | -16.79% | 1.30% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 1.50 M | $25.38 M | 346.43% | 1.12% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 1.40 M | $23.69 M | 100.00% | 1.05% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.27 M | $21.52 M | 31.65% | 0.95% |
| HRT FINANCIAL LP | 08/14/2026 | 1.24 M | $21.04 M | 147.51% | 0.93% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 1.21 M | $20.44 M | 28.33% | 0.91% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 1.21 M | $20.44 M | 100.00% | 0.91% |
| GHISALLO CAPITAL MANAGEMENT LLC | 08/14/2026 | 1.20 M | $20.30 M | 100.00% | 0.90% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 1.08 M | $18.23 M | -35.41% | 0.81% |
| WOODLINE PARTNERS LP | 08/14/2026 | 1.08 M | $18.19 M | 435.00% | 0.81% |
| STIFEL FINANCIAL CORP | 08/12/2026 | 1.01 M | $17.16 M | 0.17% | 0.76% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 976.22 K | $16.52 M | -29.35% | 0.73% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 930.23 K | $15.74 M | 100.00% | 0.70% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 921.12 K | $15.59 M | 23.13% | 0.69% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/13/2026 | 898.96 K | $15.21 M | 20.08% | 0.67% |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 07/31/2026 | 777.95 K | $13.16 M | 7.41% | 0.58% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2026 | 726.06 K | $12.28 M | 1,110.44% | 0.54% |
| FEDERATED HERMES, INC. | 08/12/2026 | 725.97 K | $12.28 M | 96.94% | 0.54% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 699.39 K | $11.83 M | 21.23% | 0.52% |
| ROYAL BANK OF CANADA | 08/14/2026 | 673.34 K | $11.39 M | 44.65% | 0.50% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 647.68 K | $10.96 M | 24.20% | 0.49% |
| MAREX GROUP PLC | 08/14/2026 | 623.60 K | $10.55 M | 0.00% | 0.47% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 577.83 K | $9.78 M | -0.28% | 0.43% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 08/14/2026 | 532.82 K | $9.02 M | -3.15% | 0.40% |
| JPMORGAN CHASE & CO | 08/12/2026 | 527.66 K | $8.87 M | -3.80% | 0.40% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 492.95 K | $8.34 M | -21.82% | 0.37% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 491.23 K | $8.31 M | 596.19% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 429.50 K | $7.27 M | -16.34% | 0.32% |
| INVESCO LTD. | 08/14/2026 | 412.01 K | $6.97 M | -5.23% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 410.65 K | $6.95 M | 25.20% | 0.31% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Intellia Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 460 institutional investors and hedge funds held shares of Intellia Therapeutics Inc. The most heavily invested institutionals were:
ARK Investment Management LLC: 16.88 M
BlackRock, Inc.: 15.41 M
STATE STREET CORP: 9.23 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 7.33 M
D. E. Shaw & Co., Inc.: 6.44 M
VANGUARD CAPITAL MANAGEMENT LLC: 6.03 M
108.80% of Intellia Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 178.34 M shares in the last 24 months. This purchase volume represents approximately $2.48 B in transactions.